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Research
Recent evidence suggests that chronic exposure 
to traffic-related air pollution (TRAP) may be 
associated with premature mortality. Dutch 
researchers demonstrated a near doubling of 
cardiopulmonary mortality for subjects living 
near major roads (Hoek et al. 2002), although 
a more recent follow-up with a larger sample 
produced generally smaller but still elevated 
risk estimates (Beelen et al. 2007). A study 
from Norway reported an increase of 18% in 
male all-cause mortality based on a comparison 
of the lowest to the highest quartile of exposure 
in nitrogen oxides estimated from a dispersion 
model (Nafstad et al. 2004). Canadian studies 
showed that subjects living close to major roads 
had mortality rate advancements of 2.5 years 
and a significant increase in all-cause mortal-
ity of 18% (Finkelstein et al. 2004). These 
large health effects might be attributable to 
higher intake fractions and subsequent doses 
for residents living near roadways (Marshall 
et al. 2005) or to the higher toxicity of traffic 
pollutants compared with other sources (Nel 
2005; Schlesinger et al. 2006).
Studies of ambient particulate mat-
ter (PM) ≤ 2.5 µm in aerodynamic diam-
eter (PM2.5) in California have shown that 
intraurban exposure gradients are associated 
with preclinical markers of atherosclerosis 
(Künzli et al. 2005) and risks of premature 
mortality (Jerrett et al. 2005). Using a sub-
cohort of about 23,000 from the American 
Cancer Society cohort in Los Angeles, Jerrett 
et al. (2005) observed relative risks (RRs) 
three times greater than those reported in 
the national study (Pope et al. 2002), with 
the major difference being the within- rather 
than between-city exposure assignment. This 
increase in the risk may have been attributable 
to more accurate exposure assignment or the 
relatively higher contribution of traffic sources 
in Los Angeles compared with other cities in 
the United States.
These recent Los Angeles studies (Jerrett 
et al. 2005; Künzli et al. 2005) used geo-
statistical interpolation models that capture 
regional patterns of pollution well, but may 
not fully account for near-source impacts 
from local traffic because of the limited vari-
ation in PM2.5 within cities and potential 
oversmoothing from the interpolation model 
used to assess exposure (Moore et al. 2007). 
The aforementioned European and Canadian 
studies used distance proxies for exposure to 
traffic, sparse government monitoring net-
works to interpolate background exposure, 
or dispersion models with limited cross- 
validation against measured data. To date, no 
study has used extensive field measurements 
with well-validated models to assess the asso-
ciation between TRAP and mortality. In this 
study, we applied 143 field measurements 
of nitrogen dioxide, an inorganic gas marker 
of TRAP, to a well-characterized cohort of 
patients from a respiratory clinic in Toronto, 
Ontario, Canada. Our objective was to assess 
the association between TRAP and mortality.
Materials and Methods
Study site description. We undertook our study 
in the City of Toronto, situated on the north-
ern shore of Lake Ontario, Canada. Toronto is 
Canada’s largest city, with a metropolitan pop-
ulation of nearly 4.7 million in 2001 (Statistics 
Canada 2001). Several busy expressways and 
numerous urban arterial roads traverse the city, 
leading to a wide range of variation in traffic 
exposures and related pollutants.
The study cohort. Subjects for this study 
were drawn from a respiratory disease clinic 
in the Toronto Western Hospital, University 
Health Network, for the purpose of studying 
the health effects of air pollution. Patients 
seen at the clinic were referred to a pul-
monologist for investigation or manage-
ment of a respiratory complaint. The study 
was approved by the research ethics boards of 
the Mt. Sinai Hospital, Toronto, and the St. 
Joseph’s Health Center, Hamilton.
All residents of Ontario are covered 
under the Ontario Health Insurance Plan 
(OHIP), a government-operated universal 
health insurance program. In 1992, unique 
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Background: Chronic exposure to traffic-related air pollution (TRAP) may contribute to  premature 
mortality, but few studies to date have addressed this topic.
oBjectives: In this study we assessed the association between TRAP and mortality in Toronto, 
Ontario, Canada.
Methods: We collected nitrogen dioxide samples over two seasons using duplicate two-sided 
Ogawa passive diffusion samplers at 143 locations across Toronto. We calibrated land use regres-
sions to predict NO2 exposure on a fine scale within Toronto. We used interpolations to predict 
levels of particulate matter with aerodynamic diameter ≤ 2.5 µm (PM2.5) and ozone levels. We 
assigned predicted pollution exposures to 2,360 subjects from a respiratory clinic, and abstracted 
health data on these subjects from medical billings, lung function tests, and diagnoses by pul-
monologists. We tracked mortality between 1992 and 2002. We used standard and multilevel Cox 
proportional hazard models to test associations between air pollution and mortality.
results: After controlling for age, sex, lung function, obesity, smoking, and neighborhood depriva-
tion, we observed a 17% increase in all-cause mortality and a 40% increase in circulatory mortality 
from an exposure contrast across the interquartile range of 4 ppb NO2. We observed no significant 
associations with other pollutants.
conclusions: Exposure to TRAP was significantly associated with increased all-cause and circulatory 
mortality in this cohort. A high prevalence of cardiopulmonary disease in the cohort probably limits 
inference of the findings to populations with a substantial proportion of susceptible individuals.
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personal health insurance numbers (HINs) 
were introduced to replace the previous insur-
ance numbers, which were family based. We 
collected the HINs and other identifiers for 
all patients treated at the clinic between 1992 
and the end of 1999.
Members of the cohort were linked to 
numerous administrative databases using 
the HIN as the identifier. These databases 
include the OHIP physician billing database, 
1992–1999; the Ontario Hospital Discharge 
Database, 1992–1999; and the Ontario 
Mortality Registry, 1992–2002. In total, 
2,414 patients with Toronto postal codes 
were identified. We extracted height, weight, 
results of lung function testing, and smoking 
history from the clinic’s database. Fifty-four 
subjects were missing data necessary to com-
pute the body mass index (BMI). Because 
BMI is an important predictor of mortality, 
and potentially a major confounder, we chose 
to exclude subjects with missing BMI data, 
rather than to impute values.
Each claim for payment submitted to 
OHIP by physicians must include a diag-
nosis code. We used the OHIP linkage to 
classify underlying respiratory disease sta-
tus by using diagnostic codes submitted to 
OHIP by specialist physicians. Diagnoses 
included chronic obstructive pulmonary dis-
ease (COPD) [International Classification of 
Diseases, 9th Revision, Clinical Modification 
(ICD-9-CM 2007) codes 491, 492, 496] and 
asthma (ICD-9 493). We classified subjects 
diagnosed with both asthma and COPD as 
having COPD (ICD-9-CM 2007). We also 
searched the OHIP billing file and Ontario 
hospital discharge database for diagnoses 
of diabetes (ICD-9-CM 250) and chronic 
ischemic heart disease (IHD) (ICD-9-CM 
412–414). Subjects were classified with these 
disorders if the diagnosis had been made in 
two or more claims submissions by a general 
practitioner, one claim submission by a spe-
cialist, or in any hospitalization.
Neighborhood contextual confounders. 
Evidence from social epidemiology suggests 
that neighborhood context may affect health 
independently beyond individual risk factors 
(Diez-Roux 2002). In Quebec, a deprivation 
index (DI) derived from the Canadian cen-
sus was correlated with premature mortality 
due to tobacco-associated causes (Pampalon 
and Raymond 2000). Because a relationship 
may exist between neighborhood context 
and traffic exposures, we used a similar index 
to adjust mortality risks across the region of 
our study to control for confounding of the 
TRAP effect. We used data from the 1996 
Census of Canada at the enumeration area 
(EA) level to derive a contextual variable. EAs 
are the smallest unit of aggregation in the 
Canadian census, with an average population 
of about 1,000. In a small number of cases 
(< 60), we assigned census tract or metro-
politan area census data because EA data were 
suppressed by Statistics Canada to protect 
privacy because of small population counts in 
the EA. We employed principal components 
to generate the DI. Analysis showed that only 
the first principal component, accounting for 
72% of the variance, was related to mortality. 
We thus retained only the first component, 
and we defined the DI as [–0.62 × log(mean 
income) + 0.58 × unemployment rate + 0.53 
× proportion of residents who did not com-
plete high school]. Higher scores on the 
DI indicate a less favorable combination of 
income, education, and employment.
Exposure assessment. We collected NO2 
samples using two-sided Ogawa passive dif-
fusion samplers at 150 locations across 
Toronto. We selected sampling locations with 
a location-allocation model based on pollu-
tion variability over space and on residential 
population density summarized elsewhere 
(Kanaroglou et al. 2005). We measured NO2 
levels across Toronto for two 2-week periods, 
one in early fall 2002 and the other in spring 
2004. To assess the reliability of the samplers, 
we deployed two samplers in tandem at each 
location during the first round of monitor-
ing, yielding a total of four separate samples 
at each location. After determining low varia-
tion between the duplicates from the 2002 
monitoring, we deployed one single two-sided 
sampler at each location, but in about 15% 
of locations we used two two-sided samplers 
for the spring 2004 sampling. During each 
sampling period, we deployed 100 Ogawa 
samplers simultaneously. This deployment 
strategy eliminated the need for tempo-
ral adjustments to the measurements before 
developing land-use regression (LUR) models 
as has been necessary in other studies (Cyrys 
et al. 2005; Hochadel et al. 2006). During 
the second round, we kept 50 locations the 
same as those in the first round and added 
50 new locations (a total 150 spatial locations 
and 143 valid measurements over the two 
sampling periods). We chose these new sites 
using the same location-allocation approach to 
improve spatial coverage of the model, whereas 
the 50 that were the same during both deploy-
ments provided an assessment of interseasonal 
correlation and hence the stability of the NO2 
spatial pattern, which we subsequently used 
to assign exposure across the cohort. We sent 
the Ogawa filters to an Environment Canada 
laboratory for analysis, where NO2 levels were 
determined by ion chromatography (Jerrett 
et al. 2007).
We derived variables employed in subse-
quent LUR models as predictors of NO2 with 
the ArcGIS 9 geographic information system 
(GIS) software (ESRI, Redlands, CA, USA). 
LUR employs the measured pollutant levels 
as the dependent variable and an array of land 
use, traffic, physical geography, and popu-
lation variables as predictors. The detailed 
modeling framework and results of the fall, 
first season of measurement are described by 
Jerrett et al. (2007), and the models used to 
predict exposures for the second, spring sea-
son are discussed by Finkelstein and Jerrett 
(2007). Briefly, we implemented a manual 
forward-selection procedure to select variables 
that explained the largest proportion of varia-
tion in NO2. We screened > 90 variables for 
each season, representing different potential 
predictors of exposure. In both models, R2 
values were nearly 0.7. Each model contained 
variables representing roadways, population 
density, land use, and the geographic x-coor-
dinate to represent a west-to-east trend of 
higher to lower NO2 across the city.
We also derived interpolated surfaces for 
PM2.5 and ozone. For the PM2.5 surface, we 
computed the annual geometric average for 
2002 from 14 Ministry of the Environment 
of Ontario (MOE) stations, equipped with 
tapered element oscillating microbalance 
monitors (hourly measurements). This was 
the first year when a spatially extensive cov-
erage of PM2.5 was available for the study 
area. For O3, we used 16 MOE sites and one 
Environment Canada site to generate annual 
averages. We computed annual averages for 
O3 for 1992, 1997, and 2002 (the beginning, 
middle, and end of the follow-up period). 
After interpolation, we averaged the three 
surfaces and assigned them to the subjects. 
The spatial domain of the samplers extended 
beyond our immediate study area to increase 
the stability of the interpolations, but the 
study area was approximately at the center 
of the interpolation surface. We performed 
interpolations using an inverse distance 
weighting algorithm in ArcGIS 9 (Burrough 
and McDonnell 1998).
Statistical model. The analysis relied on 
Cox proportional hazards regression mod-
els run in STATA version 9.0 (StataCorp., 
College Station, TX, USA).We ran models 
for all nonaccidental causes, circulatory (ICD-
9-CM 400–440), respiratory (ICD-9-CM 
460–519), and lung cancer (ICD-9-CM 
162) and, as a negative control, for all nonac-
cidental causes less circulatory, respiratory, 
and lung cancer deaths. For each outcome, 
we began with a model adjusted only for age 
and sex. We then added variables to control 
for confounding: clinical measures (BMI, 
lung function), smoking, and the DI. As a 
sensitivity analysis, we added as explanatory 
variables diagnoses of COPD, diabetes, and 
IHD, diseases probably on the causal pathway 
between pollution exposures and mortality, 
but also possibly representative of unmeas-
ured confounders such as diet or occupational 
exposure. We adjusted SEs for clustering in 
census tracts. We tested deviations from the 
Jerrett et al.
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proportional hazards assumption by introduc-
ing interactions of time with all covariates.
Results
Table 1 shows descriptive statistics for the 
cohort and the assigned exposures. In this 
sample, 48% were male, the median age was 
60 years, and about 47% were current or 
 former smokers.
Figure 1 presents a map showing the 
average of two main exposure models for 
NO2. Figure 2 shows the cumulative dis-
tribution of mean (2002 and 2004) NO2 
exposures among the study subjects. Because 
of meteoro logic variability, the magnitude of 
the 2-week average NO2 concentrations dif-
fered between seasons, and there were small 
differences in the predictors derived from 
LUR. However, the spatial patterns derived 
from the two season-specific LUR models 
were similar because the underlying pattern 
in NOx emissions, influenced largely by the 
distribution of traffic, changes little over time. 
The prediction surfaces followed a similar 
spatial pattern of high concentrations in the 
downtown and around the major highways, 
with lower concentrations in the northeast 
of the city, where there is a zoo and relatively 
little human habitation or traffic. The two 
surfaces were highly correlated after assign-
ment to the subject (Pearson’s r = 0.73), and 
were averaged for inclusion in the regression 
model [see Supplemental Material, Appendix, 
for more detail (http://www.ehponline.org/
members/2009/11533/suppl.pdf)].
There were 10,500 person-years of follow-
up in the cohort. Table 2 shows the results 
of the Cox survival models for the relations 
between interpolated NO2 and all-cause, 
circulatory, and respiratory mortality. The 
fourth column lists mortality from all nonac-
cidental causes except those in the first two 
columns. The first line of Table 2 shows mod-
els adjusted only for age and sex. The next line 
adds potential clinical confounders, including 
BMI and percent predicted forced vital capac-
ity (FVC), expressed as a percentage of the 
normal value. We found no significant asso-
ciation between mortality and forced expira-
tory volume in the first second (FEV1) when 
FVC was included in the models. In the next 
line, we adjusted the models for smoking in 
three categories (i.e., never, ever, or current 
smoking) followed by adjustment for all the 
previous variables and the DI. Finally, as a 
sensitivity analysis, we added the chronic dis-
eases COPD, IHD, and diabetes.
All-cause mortality was elevated in relation 
to the 4 ppb interquartile range (IQR) of NO2, 
with RRs ranging from 1.29 for the minimal 
adjustment model to 1.17 for the model with 
inclusion of all the control variables and adjust-
ment for clustering within the census tract of 
residence. Confounding variables generally 
reduced the size of the NO2 effect, as expected. 
Including chronic diseases confounded the rela-
tionship mildly, lowering significance to slightly 
below conventional levels [hazard ratio (HR) = 
1.15; 95% confidence interval (CI), 0.99–1.33].
Circulatory mortality was associated with 
NO2 in all models. In the model with maxi-
mal control for confounding, the RR signifi-
cantly increased by about 40% over the IQR 
Table 1. Characteristics of subjects and their neighborhoods. 
Characteristic Measure
No. of subjects  2,360
Males  1,128 (48)
Age 49, 60, 69
Smoking  
 Never 1,248 (53)
 Former 842 (36)
 Current 270 (11)
FVC (% predicted) 77, 93, 105
FEV1 (% predicted) 61, 82, 99
BMI 23.8, 27.3, 31.5
Diagnosed with asthma 462 (20)
Diagnosed with COPD 698 (30)
Diagnosed with IHD 1,129 (48)
Diagnosed with diabetes 412 (17)
Median household income (CD$1,000) 33, 39, 50
Residence within 50 m of major road or 100 m from highway 570 (24)
Interpolated NO2 (ppb) (average of 2002 and 2004 sampling) 20.8, 22.9, 24.8
Interpolated PM2.5 (µg/m3) 8.64, 8.71, 8.83
Interpolated O3 (ppb) 17.5, 18.3, 18.8
Nonaccidental deaths (no.) 299
Circulatory deaths (ICD-9-CM codes 400–449) (no.) 82 
Respiratory deaths (ICD-9-CM codes 460–519) (no.) 75 
Values are no. (%) or 25th percentile, median, and 75th percentile. 
Figure 1. Average NO2 levels based on two LUR models calibrated from 2002 fall and 2004 spring monitor-
ing campaigns with 143 monitors. Approximate subject coordinates are shifted to protect privacy.
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of NO2. We found minimal change in the 
effect estimate when we added the diagnoses 
of chronic conditions to the model or when 
we included the road buffer traffic marker 
(Table 3).
The point estimates for respiratory mortal-
ity were elevated, but the confidence inter-
vals included unity. We attempted to model 
associations between lung cancer and NO2; 
however, there were only 35 deaths in the cat-
egory, which resulted in positive estimates with 
very wide confidence intervals (results data not 
shown). The effect of NO2 exposure on other 
nonaccidental causes of death, minus cardio-
pulmonary and lung cancer mortality, was 
confounded by the clinical and socioeconomic 
variables. In the full model, we found no sig-
nificant association between these other non-
accidental causes of death and NO2 exposures.
The hypothesis of proportionality in the 
hazards was not rejected for any model. We 
tested interactions between the explanatory 
variables and NO2, but none were significant.
In a neighboring city (Hamilton, Ontario), 
we found an association between residence 
locations close to traffic and an increased 
risk in all-cause and circulatory mortal-
ity (Finkelstein et al. 2004). We applied the 
same definition of traffic proximity (residence 
within 50 m of a major road or 100 m of 
a highway) to the Toronto cohort. Table 3 
shows a large point estimate and a border-
line significant association between residential 
proximity to traffic and circulatory mortality. 
In a model that included NO2, the effect of 
NO2 was significant and the risk attributable 
to the traffic marker was lower. We found 
no relation between proximity to traffic and 
other nonaccidental causes.
Discussion
In this article we report the association 
between NO2, a marker for TRAP, and mor-
tality in a cohort of subjects drawn from a 
pulmonology clinic in Toronto. TRAP was 
associated with significant elevations in 
mortality from all causes and from circu-
latory causes. With control for confound-
ing, all-cause mortality remained elevated 
by 17% and RRs were nonsignificant only 
where adjusted for chronic diseases and the 
proximity to traffic exposure marker. Effect 
sizes over the IQR for all-cause mortality were 
similar to those reported in the Norwegian 
study (Nafstad et al. 2004).
Circulatory mortality remained sig-
nificantly elevated with RRs in the range of 
1.4 in models that controlled maximally for 
confounding and for neighborhood clustering 
on the census tracts. The HR for circulatory 
mortality was 2.28 over a 10-ppb contrast, 
which was present in the data. These effects 
are comparable in size to those reported in ear-
lier European studies (Hoek et al. 2002) and 
are consistent with findings linking coronary 
artery calcification to distance from a major 
road (Hoffmann et al. 2007). More gener-
ally, effects on circulatory outcomes have been 
demonstrated to be larger than those for other 
mortality outcomes in relation to air pollution 
(Jerrett et al. 2005; Pope et al. 2004).
Respiratory mortality was also elevated in 
relation to NO2, although models only pro-
vided nonsignificant trends. Statistical power 
to detect the effects of NO2 on lung cancer 
mortality was limited because of a small num-
ber of deaths in this category, and the results 
were inconclusive. Nonaccidental deaths less 
circulatory, respiratory, and lung cancer causes 
were not associated with TRAP in models 
that controlled for major confounders.
In a previous study in Hamilton, Ontario 
(Finkelstein et al. 2004), we reported a rela-
tion between mortality and residence close to 
traffic, as indicated by a road buffer. In this 
study, when using the same traffic buffer, we 
found a nonsignificant effect of about the 
same size as in the earlier Hamilton study. In 
a model that included both the traffic buffer 
indicator variable and NO2, the effect of NO2 
remained significant, whereas the effect of the 
traffic indicator was reduced. Mean values 
of NO2 were about 22 ppb outside the buf-
fer and about 25 ppb inside the buffer. This 
suggests that the traffic indicator is a surro-
gate for NO2 and possibly other near-source 
traffic-related exposures. Other constituents 
likely to be higher by roadways include car-
bon monoxide, ultrafine PM, volatile organic 
compounds, and elemental carbon (Reponen 
et al. 2003; Zhu et al. 2002). A recent study 
from Toronto suggests that the highest gradi-
ent in near-road exposure is in ultrafine PM 
counts (Beckerman et al. 2008).
We examined the relation between other 
exposure variables and mortality in our cohort. 
Exposure contrasts for PM2.5 and O3 were 
small in Toronto (IQR of about 1 µg/m3 or 
1 ppb, respectively), and we found no signifi-
cant associations with mortality in any of the 
models (data not shown). The combination 
of a relatively small number of deaths in the 
cohort and a limited exposure contrast lim-
ited the statistical power to detect mortality 
effects. Consequently, no definitive conclu-
sions can be drawn about these associations 
with PM2.5 and O3.
One unique strength of this study was 
our ability to control for clinically ascer-
tained preexisting conditions and lung func-
tion. These data allowed us to apply controls 
based only on self-reports in other studies 
of chronic mortality (e.g., Hoek et al. 2002; 
Jerrett et al. 2005; Pope et al. 2002). We 
included preexisting diseases as a sensitivity 
Table 2. RR (95% CI) for mortality. 
    All nonaccidental causes
    of death less circulatory,
 All nonaccidental   respiratory, and lung
Model   causes (n = 298)  Circulatory (n = 80)  Respiratory (n = 75) cancer (n = 109)
Baseline: age, sex, mean NO2  1.29 (1.13–1.48)  1.52 (1.19–1.95)  1.11 (0.84–1.47)  1.23 (0.98–1.53)
 + BMI, BMI2, FVC (% predicted)  1.24 (1.08–1.42)  1.47 (1.14–1.90)   1.10 (0.83–1.45)  1.17 (0.94–1.47)
 + Smoking (current, former, never)  1.21 (1.06–1.39)  1.44 (1.11–1.86)  1.10 (0.83–1.46)  1.12 (0.89–1.40)
 + DI  1.17 (1.01–1.35)  1.45 (1.11–1.91)  1.06 (0.79–1.43)  1.06 (0.83–1.35)
Final model clustered on census tract  1.17 (1.00–1.36)  1.45 (1.10–1.92)  1.06 (0.67–1.49)  1.06 (0.84–1.34)
Sensitivity analysis: add diagnoses of COPD, chronic IHD, and diabetes  1.15 (0.99–1.33)  1.40 (1.05–1.86)  1.09 (0.78–1.54)  1.05 (0.83–1.33)
Data are the adjusted RR per IQR increase in mean NO2 (2002 and 2004). The first line is the baseline model (age, sex, NO2), and the subsequent lines give the adjusted RR as additional 
confounders are added to the baseline model.
Table 3. RR (95% CI) for mortality in relation to residential proximity to traffic and an IQR increase in mean 
NO2 (2002 and 2004). 
   All nonaccidental causes
 All nonaccidental  of death less circulatory, 
 causes of death  respiratory, and lung
Model  (n = 298)  Circulatory (n = 80)  cancer (n = 109)
Model 1: traffic marker is the  1.19 (0.92–1.53)  1.48 (0.91–2.42)   1.17 (0.74–1.84) 
 exposure variable
Model 2: traffic marker + NO2      
 Traffic marker  1.11 (0.85–1.45)  1.22 (0.74–2.02)  1.15 (0.71–1.85)
 NO2  1.13 (0.97–1.32)  1.39 (1.05–1.85)  1.03 (0.81–1.31)
Each model was adjusted for all of the confounders controlled for in the final model from Table 2. The first result is for the 
model in which proximity to traffic is the only exposure variable. The second result is for models in which both the traffic 
marker and NO2 are included together.
Jerrett et al.
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analysis. Including these conditions may have 
overcontrolled for confounding because some 
of the variables may be on the causal pathway 
from pollution to mortality. For example, 
preclinical markers of IHD have been associ-
ated with TRAP or PM partly arising from 
traffic (Künzli et al. 2005). There is also some 
indication that COPD may associate with 
TRAP (Schikowski et al. 2005) and with dia-
betes (Brook et al. 2008). In such instances, 
inclusion of the preexisting conditions would 
remove some of the true effect attributable 
to air pollution. Even with this potential for 
overcontrol, we found only a small impact 
on the risk estimates for NO2 on all-cause 
and circulatory mortality. We subsequently 
addressed effect modification by disease status, 
but we found no significant effect modifiers 
identified. Although this cohort is enhanced 
with individuals with preexisting conditions, 
the results are generally insensitive to inclu-
sion of these conditions as either confound-
ers or effect modifiers. One explanation for 
the lack of influence of chronic disease sta-
tus as a confounder or modifier may arise 
from the role of air pollution in disease for-
mation. All of the chronic conditions tested 
were independently and positively associated 
with mortality in this cohort. If air pollution 
did contribute to disease formation, and these 
diseases were associated with elevated mortal-
ity, these disease states may not modify or 
confound the association between mortality 
and air pollution. In this case, the effects of 
air pollution would be represented in elevated 
mortality related to chronic disease status. 
This cohort lacked the statistical power to use 
structural equation models to assess the path-
way model directly, but a larger cohort is cur-
rently under construction that will allow for 
structural models to address this hypothesis.
The exposure assessment used in this 
study relied on extensive field measurements 
and models capable of predicting fine-scale 
variation in TRAP. Few other studies have 
used such an extensive network of field meas-
urements to characterize the likely ambient 
exposures. Although we took the measure-
ments over short periods, the spatial pattern 
appears relatively stable over time. For the 
43 sites where the NO2 was available in both 
rounds of measurement, the correlation coef-
ficient r-value was 0.82, and both seasons had 
a similar spatial structure [see Supplemental 
Material, Appendix, for details (http://www.
ehponline.org/members/2009/11533/suppl.
pdf)]. The relative stability over time of the 
spatial pattern of pollutant concentrations 
derived from short-term saturation moni-
toring has been reported by others (Lebret 
et al. 2000; Sahsuvaroglu et al. 2006). Thus, 
although the measurement period for NO2 
was at or beyond the end of mortality follow- 
up, there is evidence suggesting spatial 
exposure contrast observed from these shorter 
periods captures the essential aspects of the 
chronic exposure experience for the cohort. 
With the accurate predictions from the LUR 
models, the assigned exposures appear to 
reduce measurement error, which may have 
contributed to the large effect size for circu-
latory mortality. The road distance buffers 
tested here and used in comparable studies 
(Finkelstein et al. 2004) did produce elevated 
risks, but with less certainty than with the 
predicted NO2 concentrations, as would be 
expected from a less precise exposure estima-
tor (Molitor et al. 2007). The exposure assess-
ment appears to diminish measurement error 
and produce more certain estimates, but we 
are unable to comment directly on which spe-
cific constituents of the pollutant mixture are 
linked to the health effects. Research efforts 
are under way to measure speciated PM and 
volatile organic compounds to better under-
stand what constituents of the traffic mixture 
are most closely related to the observed risks.
We based NO2 estimates on two simul-
taneous 2-week monitoring periods. This 
method obviates the need to account for tem-
poral effects in different measurements, but 
for most of the year we had no monitoring 
at these locations. This approach may have 
resulted in invalid estimates of the annual 
average. To assess this possibility, we com-
piled 2-week averages for the downtown 
Toronto central monitoring site operated by 
the Ontario MOE. We compared the 2-week 
averages with the annual averages based on 
daily data. The annual average was 23.2 ppb, 
with a minimum of 18.9 ppb and maximum 
of 30.9 ppb. The mean difference in absolute 
values between the 2-week average and the 
annual average is 2.39 ppb, with a maximum 
difference of 7.72 ppb and a minimum dif-
ference of 0.014 ppb. On average, then, we 
found about a 10% difference between the 
annual mean and the 2-week averages. In an 
earlier publication documenting the exposure 
modeling (Jerrett et al. 2007), we compared 
the 2-week average values to the monthly aver-
age and 5-year averages at the three govern-
ment monitors where co-located measurements 
were available. The NO2 levels were within 
4.1–27.7% of the 5-year average. These analy-
ses suggest that the two simultaneous 2-week 
samples probably reflect the annual and 5-year 
average values well. Similar studies in Southern 
California indicated high interclass correlations 
> 0.9 between the annual mean and two or 
three 2-week average measurements of NO2 
(Gilliland et al. 2005).
Other risk factors near roadways may also 
have contributed to the elevated mortality. 
Traffic noise is a particular concern given simi-
lar source contributions compared with NO2 
and the previous research linking traffic noise 
to elevated myocardial infarctions (Babisch 
et al. 2005). In this study, we are unable to rule 
out confounding by noise, and there may be 
residual influence from this unmeasured risk 
factor. Studies combining noise and air pollu-
tion exposure are a priority for future research.
Because we used existing clinic data rather 
than prospectively collected information, we 
did not obtain some valuable information on 
individual risk factors. For example, socio-
economic status was not available at the indi-
vidual level, although neighborhood data did 
appear to be a useful surrogate. There is thus 
the possibility of residual confounding by 
individual factors that could not be measured 
with this study design.
Although this study benefited from a well-
characterized clinical cohort, generalizability 
of the results could be questioned given the 
high prevalence of chronic diseases relative to 
the general population: Nearly half the sub-
jects had been diagnosed with IHD, and 30% 
had COPD. The high prevalence of cardio-
pulmonary disease in the cohort probably lim-
its inference of the findings to populations with 
a substantial proportion of susceptible indi-
viduals. The results must also be viewed with 
the caveat that the sample size was smaller than 
in other cohort studies of mortality, and with 
small samples there is a higher possibility of 
chance findings. In follow-up research, a larger 
more representative sample of patients from 
general-practice clinics will be investigated.
The reported findings may be influenced 
by the inclusion of susceptible individuals, 
but the large risks uncovered here and in the 
few other studies focused on traffic impli-
cate TRAP as a risk to public health. When 
viewed in the context of increasing miles trav-
eled (Frumkin et al. 2004) and the rapid rise 
in automobile sales in newly industrialized 
nations such as China and India (Molina and 
Molina 2004), the health effects observed 
here may have growing relevance in relation 
to the prevention of disease and premature 
mortality.
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